Ziad Mallat

Q: What Schools Are Affiliated With Ziad Mallat

Ziad Mallat is affiliated with the following schools: Lebanese University, Paris Diderot University, Sorbonne University, University of Cambridge, Leiden University, Medical University of Vienna, University of Oxford, University College London, Imperial College London, KU Leuven, Stanford University

Ziad Mallat's AcademicInfluence.com Rankings

Ziad Mallat

Computer Science

#5217

World Rank

#5511

Historical Rank

Data Science

#80

World Rank

#82

Historical Rank

Algorithms

#177

World Rank

#180

Historical Rank

Computational Linguistics

#673

World Rank

#685

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Ziad Mallat's Degrees

Bachelors Mathematics Imperial College London

Similar Degrees You Can Earn

Best Online Bachelor's in Math Ranked

Why Is Ziad Mallat Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ziad Mallat's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cytokines in atherosclerosis: pathogenic and regulatory pathways. (2006) (1618)
Natural regulatory T cells control the development of atherosclerosis in mice (2006) (1033)
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. (2000) (945)
Protective role of interleukin-10 in atherosclerosis. (1999) (843)
Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice (2008) (647)
Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. (1999) (644)
Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability (2001) (586)
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. (2005) (541)
Recent Advances on the Role of Cytokines in Atherosclerosis (2011) (529)
Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction (2001) (525)
Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice (2003) (507)
Inhibition of Transforming Growth Factor-&bgr; Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice (2001) (465)
Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. (1998) (446)
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. (2000) (445)
Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. (1996) (439)
Vascular smooth muscle cells in atherosclerosis (2019) (438)
Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. (2000) (414)
B cell depletion reduces the development of atherosclerosis in mice (2010) (413)
Anti-Inflammatory Mechanisms in the Vascular Wall (2001) (407)
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis (2009) (403)
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction (2013) (401)
Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. (2007) (383)
Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability (2001) (380)
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. (2010) (353)
Apoptosis in the vasculature: mechanisms and functional importance (2000) (348)
Inhibition of MicroRNA-92a Prevents Endothelial Dysfunction and Atherosclerosis in Mice (2014) (336)
Induction of a Regulatory T Cell Type 1 Response Reduces the Development of Atherosclerosis in Apolipoprotein E–Knockout Mice (2003) (320)
Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. (2000) (307)
Lactadherin promotes VEGF-dependent neovascularization (2005) (292)
Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. (1999) (283)
Lactadherin Deficiency Leads to Apoptotic Cell Accumulation and Accelerated Atherosclerosis in Mice (2007) (250)
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile (2010) (245)
Protective Role of Uncoupling Protein 2 in Atherosclerosis (2003) (239)
Monocytes and macrophages in abdominal aortic aneurysm (2017) (224)
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets (2011) (222)
Antiangiogenic Effect of Interleukin-10 in Ischemia-Induced Angiogenesis in Mice Hindlimb (2000) (215)
The role of adaptive T cell immunity in atherosclerosis Ziad Mallat is a recipient of a Contrat d'Interface from Assistance Publique-Hôpitaux de Paris. Published, JLR Papers in Press, December 2, 2008. (2009) (207)
Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome (2015) (204)
In Vivo Induction of Endothelial Apoptosis Leads to Vessel Thrombosis and Endothelial Denudation: A Clue to the Understanding of the Mechanisms of Thrombotic Plaque Erosion (2004) (200)
Current perspective on the role of apoptosis in atherothrombotic disease. (2001) (197)
IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. (2015) (196)
Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice* (2002) (195)
Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure (2001) (188)
Macrophages (2021) (187)
Apoptotic cell death and efferocytosis in atherosclerosis. (2012) (182)
The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. (1999) (180)
Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis (2014) (177)
Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice (2004) (174)
Defective Mer Receptor Tyrosine Kinase Signaling in Bone Marrow Cells Promotes Apoptotic Cell Accumulation and Accelerates Atherosclerosis (2008) (169)
Lipoprotein-Associated and Secreted Phospholipases A2 in Cardiovascular Disease: Roles as Biological Effectors and Biomarkers (2010) (165)
Increased plasma concentrations of interleukin-18 in acute coronary syndromes (2002) (162)
In Vivo Shear Stress Determines Circulating Levels of Endothelial Microparticles in End-Stage Renal Disease (2007) (159)
Evidence for altered interleukin (IL)‐18 pathway in human heart failure (2004) (152)
Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. (2003) (151)
Transplantation of Bone Marrow–Derived Mononuclear Cells in Ischemic Apolipoprotein E–Knockout Mice Accelerates Atherosclerosis Without Altering Plaque Composition (2003) (151)
Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. (2013) (151)
The role of B cells in atherosclerosis (2018) (151)
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health (2018) (151)
Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. (2000) (147)
Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events. (2010) (145)
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes. (2005) (142)
BAFF Receptor Deficiency Reduces the Development of Atherosclerosis in Mice—Brief Report (2012) (141)
Post-ischaemic neovascularization and inflammation. (2008) (135)
NLRP3 inflammasome pathways in atherosclerosis. (2017) (135)
Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study (2011) (129)
Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From Atherosclerosis (2007) (124)
Circulating Secretory Phospholipase A2 Activity and Risk of Incident Coronary Events in Healthy Men and Women: The EPIC-NORFOLK Study (2007) (123)
Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. (2001) (120)
Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice (2012) (119)
Rho-Associated Protein Kinase Contributes to Early Atherosclerotic Lesion Formation in Mice (2003) (119)
Regulatory T-cell immunity in atherosclerosis. (2007) (115)
Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb‐IIIa antagonists (2004) (115)
Apoptosis as a Determinant of Atherothrombosis (2001) (114)
MFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injury. (2013) (113)
Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review. (2019) (111)
Regulatory T‐cell immunity and its relevance to atherosclerosis (2008) (106)
Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. (2008) (102)
Regulation of Matrix Metalloproteinase Activity in Ischemic Tissue by Interleukin-10: Role in Ischemia-Induced Angiogenesis (2001) (102)
Regulatory T cell responses: potential role in the control of atherosclerosis (2005) (99)
Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet (2017) (96)
Role of Bone Marrow–Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice (2006) (95)
Smooth muscle cells : another source of tissue factor-containing microparticles in atherothrombosis? (2000) (95)
Diabetes and aortic aneurysm: current state of the art (2018) (94)
Age and gender effects on cardiomyocyte apoptosis in the normal human heart. (2001) (94)
Evidence of a role for lactadherin in Alzheimer's disease. (2007) (93)
Adaptive T cell immune responses and atherogenesis. (2010) (92)
Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor (2016) (91)
Natural Regulatory T Cells Limit Angiotensin II–Induced Aneurysm Formation and Rupture in Mice (2013) (90)
Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production. (2015) (88)
Vascular Smooth Muscle Cell Plasticity and Autophagy in Dissecting Aortic Aneurysms (2019) (88)
The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives (2002) (87)
Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension. (2012) (85)
Targeting B cells in atherosclerosis: closing the gap from bench to bedside. (2015) (84)
Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization. (2010) (82)
Regulatory T Cells Modulate Postischemic Neovascularization (2009) (82)
MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism (2017) (81)
Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. (2008) (81)
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. (2013) (80)
MHC Class II–Restricted Antigen Presentation by Plasmacytoid Dendritic Cells Drives Proatherogenic T Cell Immunity (2014) (80)
Type-2 innate lymphoid cells control the development of atherosclerosis in mice (2017) (80)
Angiotensin II Mobilizes Spleen Monocytes to Promote the Development of Abdominal Aortic Aneurysm in Apoe−/− Mice (2015) (79)
Secretory Phospholipase A2-IIA and Cardiovascular Disease (2013) (78)
Conflicting vascular and metabolic impact of the IL-33/sST2 axis. (2018) (78)
Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. (1997) (78)
Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. (2009) (76)
In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. (2011) (75)
Cross-sectional associations between physical activity and selected coronary heart disease risk factors in young adults. The Cardiovascular Risk in Young Finns Study (2012) (73)
Prediction of head-up tilt test result by analysis of early heart rate variations. (1997) (73)
Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Ischemia-Induced Neovascularization in Mice Hindlimb (2002) (73)
Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. (2002) (72)
Inhibition of IL-17A in atherosclerosis. (2011) (72)
Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation. (2007) (70)
Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis. (2016) (69)
Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. (2013) (68)
Diagnostic and therapeutic strategies for small abdominal aortic aneurysms (2011) (68)
Chemokine Receptor CCR1 Disruption in Bone Marrow Cells Enhances Atherosclerotic Lesion Development and Inflammation in Mice (2005) (67)
Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation. (2001) (67)
Interleukin-17: friend or foe in atherosclerosis? (2010) (64)
Cytokine network and T cell immunity in atherosclerosis (2009) (64)
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial (2018) (63)
Frequent and Widespread Vascular Abnormalities in Human Signal Transducer and Activator of Transcription 3 Deficiency (2012) (61)
Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. (2009) (61)
Group X Secreted Phospholipase A2 Limits the Development of Atherosclerosis in LDL Receptor–Null Mice (2013) (61)
Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells (2016) (58)
Reversal of Hypoxia in Murine Atherosclerosis Prevents Necrotic Core Expansion by Enhancing Efferocytosis (2014) (57)
Bone Marrow Transplantation Reveals the in Vivo Expression of the Mitochondrial Uncoupling Protein 2 in Immune and Nonimmune Cells during Inflammation* (2003) (57)
The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology. (2017) (56)
Systemic chemokine levels, coronary heart disease, and ischemic stroke events (2011) (56)
Regulatory B Cell–Specific Interleukin-10 Is Dispensable for Atherosclerosis Development in Mice (2015) (55)
Phospholipase A2 Enzymes, High-Dose Atorvastatin, and Prediction of Ischemic Events After Acute Coronary Syndromes (2012) (55)
Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia1 (2012) (53)
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart (2016) (53)
Micro-RNAs in abdominal aortic aneurysms: insights from animal models and relevance to human disease. (2016) (51)
Circulating microparticles and procoagulant activity in elderly patients. (2010) (50)
Necrotic Cell Sensor Clec4e Promotes a Proatherogenic Macrophage Phenotype Through Activation of the Unfolded Protein Response (2016) (50)
Magnetic Resonance Molecular Imaging of Thrombosis in an Arachidonic Acid Mouse Model Using an Activated Platelet Targeted Probe (2010) (49)
Oxygen-regulated protein-150 prevents calcium homeostasis deregulation and apoptosis induced by oxidized LDL in vascular cells (2008) (47)
Increased Plasma IgE Accelerate Atherosclerosis in Secreted IgM Deficiency (2017) (47)
Impairment in Postischemic Neovascularization in Mice Lacking the CXC Chemokine Receptor 3 (2005) (45)
Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling (2020) (43)
Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality. (2012) (41)
Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation (2001) (41)
Selective EGF-Receptor Inhibition in CD4+ T Cells Induces Anergy and Limits Atherosclerosis. (2018) (41)
MicroRNAs as therapeutic targets in atherosclerosis (2015) (39)
Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2 (2017) (39)
Multiple potential roles for B cells in atherosclerosis (2014) (38)
Overexpression of SOCS3 in T Lymphocytes Leads to Impaired Interleukin-17 Production and Severe Aortic Aneurysm Formation in Mice—Brief Report (2013) (38)
The role of the inflammasome in cardiovascular diseases (2014) (38)
Immunomodulation to combat atherosclerosis: the potential role of immune regulatory cells (2004) (37)
TGF&bgr; (Transforming Growth Factor-&bgr;) Blockade Induces a Human-Like Disease in a Nondissecting Mouse Model of Abdominal Aortic Aneurysm (2017) (37)
Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet. (2009) (35)
The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections (2017) (35)
Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction (2018) (35)
Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. (2010) (35)
IAP Survivin Regulates Atherosclerotic Macrophage Survival (2007) (35)
Atheroprotective effect of CD31 receptor globulin through enrichment of circulating regulatory T-cells. (2007) (35)
Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development (2018) (34)
French Intensive Care Society, International congress – Réanimation 2016 (2016) (33)
Neuroimmune cardiovascular interfaces control atherosclerosis (2022) (33)
Immune-mediated mechanisms of atherosclerosis and implications for the clinic (2016) (33)
Secreted IgM deficiency leads to increased BCR signaling that results in abnormal splenic B cell development (2017) (32)
Frequent and widespread vascular abnormalities in human STAT3 deficiency (2011) (32)
Metabolic Syndrome and Carotid Intima-Media Thickness in Young Adults: Roles of Apolipoprotein B, Apolipoprotein A-I, C-Reactive Protein, and Secretory Phospholipase A2: The Cardiovascular Risk in Young Finns Study (2010) (31)
Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy (2013) (31)
Impaired Autophagy in CD11b+ Dendritic Cells Expands CD4+ Regulatory T Cells and Limits Atherosclerosis in Mice (2019) (31)
Circulating procoagulant microparticles in acute pulmonary embolism: a case-control study. (2010) (30)
Can Statins Reduce the Inflammatory Response to Cardiopulmonary Bypass? A Clinical Study (2001) (30)
Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). (2015) (29)
Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation (2014) (29)
Platelets in atherosclerosis: a new role for beta-amyloid peptide beyond Alzheimer's disease. (2002) (28)
MicroRNA‐21 Coordinates Human Multipotent Cardiovascular Progenitors Therapeutic Potential (2014) (28)
Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice. (2019) (28)
Measles Virus Nucleoprotein Induces a Regulatory Immune Response and Reduces Atherosclerosis in Mice (2007) (28)
IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure. (2018) (28)
B Cell–Activating Factor Neutralization Aggravates Atherosclerosis (2018) (27)
X-Box Binding Protein-1 Dependent Plasma Cell Responses Limit the Development of Atherosclerosis (2017) (27)
Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients (2016) (27)
The atheroprotective effect of 17 beta-estradiol is not altered in P-selectin- or ICAM-1-deficient hypercholesterolemic mice. (2003) (27)
Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells. (2012) (27)
The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice (2017) (27)
Role of Microvascular Tone and Extracellular Matrix Contraction in the Regulation of Interstitial Fluid: Implications for Aortic Dissection. (2016) (27)
Selective EGFR (Epidermal Growth Factor Receptor) Deletion in Myeloid Cells Limits Atherosclerosis—Brief Report (2018) (27)
Human Bartonella Infective Endocarditis is Associated with High Frequency of Antiproteinase 3 Antibodies (2014) (26)
Apoptosis, a major determinant of atherothrombosis. (2003) (26)
Novel Genetic Approach to Investigate the Role of Plasma Secretory Phospholipase A2 (sPLA2)-V Isoenzyme in Coronary Heart Disease: Modified Mendelian Randomization Analysis Using PLA2G5 Expression Levels (2014) (25)
Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages (2020) (25)
TREM-1 orchestrates Angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm. (2020) (24)
An Unexpected Intriguing Effect of Toll-Like Receptor Regulator RP105 (CD180) on Atherosclerosis Formation With Alterations on B-Cell Activation (2013) (23)
MARK4 controls ischaemic heart failure through microtubule detyrosination (2021) (23)
Deletion of IRF8 (Interferon Regulatory Factor 8)-Dependent Dendritic Cells Abrogates Proatherogenic Adaptive Immunity (2018) (22)
Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells (2017) (22)
BAFF Neutralization Aggravates Atherosclerosis (2018) (22)
APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans (2021) (22)
Readapting the adaptive immune response – therapeutic strategies for atherosclerosis (2017) (22)
In vivo electrotransfer of interleukin-10 cDNA prevents endothelial upregulation of activated NF-kappaB and adhesion molecules following an atherogenic diet. (2006) (22)
Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells (2018) (21)
Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet (2018) (20)
Type II Secretory Phospholipase A2 and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study (2011) (20)
[Right precordial leads and sudden death. Relation with arrhythmogenic right ventricular dysplasia]. (1996) (20)
Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study (2021) (20)
NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice—Brief Report (2020) (19)
Oxidative Stress and Inflammatory Markers in Abdominal Aortic Aneurysm (2021) (19)
Aseptic meningoencephalitis after iopamidol myelography (1991) (18)
Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease. (2011) (18)
Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function Following Myocardial Infarction Through Kynurenine. (2020) (18)
MicroRNA-21 Deficiency Alters the Survival of Ly-6Clo Monocytes in ApoE−/− Mice and Reduces Early-Stage Atherosclerosis—Brief Report (2019) (18)
Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction (2021) (16)
Secretory Phospholipase A2-IIA and Cardiovascular Disease A Mendelian Randomization Study (2017) (16)
PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk (2015) (16)
IL‐21 promotes myocardial ischaemia/reperfusion injury through the modulation of neutrophil infiltration (2018) (15)
Gingival fibroblasts protect against experimental abdominal aortic aneurysm development and rupture through tissue inhibitor of metalloproteinase-1 production (2017) (15)
Cytokines as regulators of atherosclerosis in murine models. (2007) (15)
B Cell Fcγ Receptor IIb Modulates Atherosclerosis in Male and Female Mice by Controlling Adaptive Germinal Center and Innate B-1-Cell Responses (2019) (14)
Phospholipase A 2 Enzymes, High-Dose Atorvastatin, and Prediction of Ischemic Events After Acute Coronary Syndromes Aggressive (2012) (14)
Age and gender effects on apoptosis in the human coronary arterial wall (2005) (14)
Plan B (-cell) in atherosclerosis. (2017) (13)
HDL, PTX3, and vascular protection. (2008) (13)
Association of Residual Plasma Viremia and Intima-Media Thickness in Antiretroviral-Treated Patients with Controlled Human Immunodeficiency Virus Infection (2014) (13)
Role of splenic monocytes in atherosclerosis (2015) (13)
Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice. (2022) (13)
Differential micro-RNA expression in diabetic patients with abdominal aortic aneurysm. (2019) (13)
TGF β (Transforming Growth Factor- β ) Blockade Induces a Human-Like Disease in a Nondissecting Mouse Model of Abdominal Aortic Aneurysm (2017) (13)
Deletion of Chromosome 9p21 Noncoding Cardiovascular Risk Interval in Mice Alters Smad2 Signaling and Promotes Vascular Aneurysm (2014) (12)
[Atherosclerotic plaque formation]. (1999) (12)
Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies. (2021) (12)
Transforming growth factor β neutralization finely tunes macrophage phenotype in elastase-induced abdominal aortic aneurysm and is associated with an increase of arginase 1 expression in the aorta. (2019) (11)
MARK4 (Microtubule Affinity-Regulating Kinase 4)-Dependent Inflammasome Activation Promotes Atherosclerosis. (2019) (11)
IL-33 (Interleukin 33)/sST2 (Soluble Suppression of Tumorigenicity 2) Axis in Hypertension and Heart Failure (2018) (11)
IL-33 Induces Type-2-Cytokine Phenotype but Exacerbates Cardiac Remodeling Post-Myocardial Infarction with Eosinophil Recruitment, Worsened Systolic Dysfunction, and Ventricular Wall Rupture. (2020) (10)
Hypertension: a novel regulator of adaptive immunity in atherosclerosis? (2004) (10)
Association between type II secretory phospholipase A 2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease (2009) (10)
AT1 receptor antagonism to reduce aortic expansion in Marfan syndrome: lost in translation or in need of different interpretation? (2015) (9)
Interleukin‐10: an anti‐atherogenic cytokine? (2001) (9)
Macrophage beta2-adrenergic receptor is dispensable for the adipose tissue inflammation and function (2021) (9)
Apoptosis and expression of heme oxygenase-1 in heart transplant recipients during acute rejection episodes. (2002) (8)
In vivo shear stress determines circulating levels of endothelial microparticles (2006) (8)
The effects of dyslipidaemia and cholesterol modulation on erythrocyte susceptibility to malaria parasite infection (2019) (8)
Athérosclérose et inflammation (2001) (8)
Apoptose et syndromes coronariens aigus (2004) (8)
Immune And Inflammatory Mechanisms Mediate Cardiovascular Diseases From Head To Toe. (2021) (8)
Lp-PLA2 et sPLA2 - Biomarqueurs cardiovasculaires (2014) (8)
Sialyltransferase activity and atherosclerosis. (2014) (7)
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease (2021) (7)
Apoptosis and expression of heme oxygenase-1 in heart transplant recipients during acute rejection episode. (2002) (7)
2019 ATVB Plenary Lecture (2019) (7)
CCN2 (Cellular Communication Network Factor 2) Deletion Alters Vascular Integrity and Function Predisposing to Aneurysm Formation (2021) (7)
Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS) (2020) (7)
Serum secreted phospholipase A2 is associated with abdominal aortic aneurysm presence but not progression. (2011) (7)
Vasoreactivity at culprit lesions. (1995) (7)
Macrophages (2014) (7)
MFGE8 does not orchestrate clearance of apoptotic neurons in a mouse model of Parkinson's disease (2013) (7)
Mouse models of atherosclerosis (2007) (6)
Unbalanced RANKL/RANK pathway in aortic valve sclerosis. (2004) (6)
L’athérosclérose : une maladie inflammatoire (2008) (6)
Dendritic Cell-Derived TSLP Negatively Regulates HIF-1α and IL-1β During Dectin-1 Signaling (2019) (6)
Cytokines and Atherosclerosis (2010) (6)
The B-side story in insulin resistance (2011) (6)
The why and how of adaptive immune responses in ischemic cardiovascular disease (2022) (5)
Coronary Heart Disease Phospholipase A 2 Enzymes , High-Dose Atorvastatin , and Prediction of Ischemic Events After Acute Coronary Syndromes (2012) (5)
Matrix metalloproteinase-8 and the regulation of blood pressure, vascular inflammation, and atherosclerotic lesion growth. (2009) (5)
Serotonin 5-HT 2 B receptors are required for bone-marrow contribution to pulmonary arterial hypertension (2011) (5)
In Vivo Characterization of a New Abdominal Aortic Aneurysm Mouse Model with Conventional and Molecular MRI (2009) (4)
The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice. (2015) (4)
Clonal hematopoiesis is not significantly associated with COVID-19 disease severity (2022) (4)
Interleukin-2 therapy in cardiovascular disease: the potential to regulate innate and adaptive immunity (2020) (4)
Pathobiology of Atherosclerosis (1999) (4)
Rate of apoptosis in human atherosclerosis. (1998) (4)
[Interleukin-10: an anti-atherogenic cytokine]. (2001) (4)
Molecular mechanisms of cardiac myocardial remodeling during aging. Role of apoptosis (2000) (4)
Regulating heart repair with cardiac-specific T lymphocytes. (2019) (4)
A neuropathological study of cerebrovascular abnormalities in a signal transducer and activator of transcription 3-deficient patient. (2015) (4)
PET Imaging of Post-infarct Myocardial Inflammation (2021) (4)
La lactadhérine, nouvel acteur de l’angiogenèse (2005) (3)
Abstract 4998: Elevated Oxidized Phospholipids on Apolipoprotein B-100 Particles Predict 6-Year Cardiovascular Events in the Epic-Norfolk Study: Potentiation of Risk with Lipoprotein-Associated (Lp-PLA2) and Soluble Phospholipase A2 (sPLA2) Activity (2008) (3)
Abstract 1131: The Prognostic Utility of Secretory Phospholipase A2 in Patients With Stable Coronary Artery Disease (2009) (3)
Nationwide study in France investigating the impact of diabetes on mortality in patients undergoing abdominal aortic aneurysm repair (2021) (3)
Abstract 728: Natural CD4+CD25+ Regulatory T Cells Control The Development Of Abdominal Aortic Aneurysm (2007) (3)
Thymic stromal lymphopoietin is a key cytokine for the immunomodulation of atherogenesis with Freund's adjuvant (2020) (3)
Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: a 21-year cohort. (2018) (3)
Metabolic Syndrome and Carotid Intima-Media Thickness in Young Adults : Roles of Apolipoprotein B , Apolipoprotein A-I , C-Reactive Protein , and Secretory Phospholipase A 2 : The Cardiovascular Risk in Young Finns Study (2010) (3)
Rituximab in patients with acute ST-elevation myocardial infarction (RITA-MI) (2020) (3)
JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm (2022) (3)
NF-κB activation in atherosclerosis: a friend or a foe? (2004) (3)
The spoils of war and the long-term spoiling of health conditions of entire nations (2022) (3)
Balance inflammatoire et athérosclérose (2003) (3)
561. Phase 3 Trial of Fostamatinib for the Treatment of COVID-19: Repurposing an Immunomodulatory Drug Previously Approved for Immune Thrombocytopenia (2021) (2)
Commentary: Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells (2017) (2)
Beating (T-lymphocyte driven) atherosclerosis with B- and T-lymphocyte attenuator (2020) (2)
Reply: limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease. (2014) (2)
Arteries or veins?: VEGF helps EPCs choose their cAMP. (2006) (2)
Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial (2020) (2)
775-4 Effects of Stretch and Pressure-induced Crush of the Arterial Wall on the Induction of Immediate Early Protooncogenes (1995) (2)
[Acute coronary thrombosis]. (2003) (2)
Abstract 675: Role of Indoleamine 2,3-dioxygenase in Atherosclerosis Development (2014) (2)
Abnormal myocardial development. (1997) (2)
Abstract 16204: Circulating Levels of sTREM-1 and Mortality in Patients With an Acute Myocardial Infarction (2014) (2)
Unravelling immune cell complexity in atherosclerosis. (2018) (2)
Interleukine-10 : une cytokine anti-athérogène ? (2001) (2)
[Lp-PLA2 and sPLA2: cardiovascular biomarkers]. (2014) (2)
THE EFFECT OF HIGH DOSE STATIN THERAPY ON LIPOPROTEIN-ASSOCIATED AND SECRETORY PHOSPHOLIPASE A2 MASS AND ACTIVITY AND ISCHEMIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES (2010) (2)
Abstract 5164: Loss of SOCS3 Expression in T Cells Reveals a Regulatory Role for Interleukin-17 in Atherosclerosis (2009) (2)
Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6Chi monocytes and differentiation to pro-angiogenic myeloid cells (2022) (2)
Abstract 757: Defective Leptin Signaling Improves Regulatory T Cell Immune Response And Protects Mice From Atherosclerosis (2007) (2)
PI3Kgamma helps an SDF seeking home... for EPCs. (2008) (2)
MHC Class II-Restricted Antigen Presentation by Plasmacytoid Dendritic Cells Drives Pro-Atherogenic T Cell Immunity (2014) (2)
HEART RATE INCREASES IN TILT TEST. AUTHORS' REPLY (1998) (2)
L'athérosclérose: une maladie inflammatoire (2009) (2)
0221: MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential and post-ischemic revascularization (2014) (2)
Suppression of Hematopoiesis in Recurrent Myocardial Infarction: A Deadly Silence. (2020) (1)
[Etiopathogenesis of arrhythmogenic right ventricular dysplasia]. (2000) (1)
Dietary sucrose induces more atherosclerosis than dietary fat in LDLr-/- ApoB100/100 mice: Is it independent of differences in plasma cholesterol levels? (2021) (1)
Véronique Response and Protects Mice From Atherosclerosis Defective Leptin / Leptin Receptor Signaling Improves Regulatory T Cell Immune (2007) (1)
[Apoptosis in the cardiovascular system]. (1999) (1)
Editorial: Inflammation and Reparative Process After Cardiac Injury (2019) (1)
206 B Cell-Specific FC Gamma Receptor IIB Over-Expression Enhances Atherosclerosis by Inhibiting B1 Cells (2016) (1)
External stenting & atherosclerosis (1998) (1)
The year 2019 in Atherosclerosis. (2020) (1)
Atenolol versus Losartan in Marfan's Syndrome. (2015) (1)
PI3K (cid:1) Helps an SDF Seeking Home . . . for EPCs (2008) (1)
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis (2023) (1)
[Apoptosis and acute coronary syndromes]. (2004) (1)
Abstract 18838: Inhibition and Genetic Deficiency of Trem-1 Receptor Reduces Development of Experimental Atherosclerosis in Mice (2014) (1)
The semicarbazide-sensitive amine oxidase (SSAO): A new actor in atherosclerosis in the APOE mouse model? (2011) (1)
Abstract 9224: Depletion of Mature B cells by Deletion of BAFF Receptor Reduces Atherosclerosis in ldlr Knockout Mice (2011) (1)
Exploring the role of TREM-1 receptor in experimental Abdominal Aortic Aneurysm (2018) (1)
Les lymphocytes T régulateurs protègent contre le développement de l’athérosclérose (2006) (1)
Suppressive oligodeoxynucleotides inhibit atherosclerosis. (2008) (1)
[Role of inflammation in coronary artery disease]. (2015) (1)
Rôle du TGFβ dans un modèle d’anévrisme de l’aorte abdominale chez la souris (2010) (1)
ATVB in focus. Monocyte subsets and their relevance to cardiovascular diseases. Editorial. (2009) (1)
The year 2020 in Atherosclerosis. (2021) (1)
Immune regulation in atherosclerosis and the hygiene hypothesis (2009) (1)
Rôle des chimiokines dans l’athérosclérose : complémentarité des recherches fondamentales et cliniques dans l’élaboration de stratégies thérapeutiques (2006) (1)
Meningoencephalitis due to penicillin-resistantStreptococcus pneumoniae (2005) (1)
[Role of TGF-ß in a model of abdominal aortic aneurysm in mice]. (2010) (1)
Abstract 5459: Unexpected Acceleration of Atherosclerosis in Ldlr-null Mice Reconstituted With Group X Secretory Phospholipase A2-Deficient Bone Marrow (2009) (1)
[Apoptosis and vascular remodeling]. (1999) (1)
Mediators of Vascular Inflammation (2012) (1)
Biological Effectors and Biomarkers in Cardiovascular Disease : Roles 2 Lipoprotein-Associated and Secreted Phospholipases (2010) (0)
Immune mechanisms of atherosclerosis (2013) (0)
Role of indoleamine 2,3 dioxygenase in abdominal aortic aneurysm development (2017) (0)
Edinburgh Research Explorer Secretory Phospholipase A2-IIA and Cardiovascular Disease (2018) (0)
O2 LOSS OF AUTOPHAGY IN DENDRITIC CELLS PROMOTES CD4+ TREG EXPANSION AND LIMITS THE DEVELOPMENT OF ATHEROSCLEROSIS IN MICE (2018) (0)
Association between serum secretory phospholipase A2 and risk of ischaemic stroke (2021) (0)
Pro-atherogenic diet accelerates tumor growth in mice through IL-1β and myeloid cell-derived VEGF-A (2020) (0)
Combinaison de facteurs de risque cardiovasculaire lp(a) et d'activité de spla2 pour le diagnostic/pronostic d'une maladie/d'un événement cardiovasculaire (2009) (0)
Card9 deficiency accelerates experimental atherosclerosis (2018) (0)
Mallat Recent Highlights : Macrophages 2511 (0)
[New biological concepts in cardiovascular pathology]. (2006) (0)
P20 ERYTHROCYTE-DERIVED INTERLEUKIN-33 INSTRUCTS THE SPECIFICATION OF IRON-RECYCLING MACROPHAGES (2018) (0)
Use of IL-18 inhibitors for treatment and / or prevention of atherosclerosis (2001) (0)
The Neutralization of TGF Beta Modulates the Phenotype of the Macrophages in a Murine Model of Aneurysm Induced by Elastase and Leads to an Increase in arginase-1 (2018) (0)
Abstract 335: M.R Imaging of an Arachidonic Acid Induced Mouse Model of Thrombosis Using an Activated Platelets Targeted Paramagnetic Contrast Agent (2009) (0)
Role of leukocyte-derived CC-Chemokine receptor 5 in the development of atherosclerosis of low density lipoprotein receptor knockout mice (2006) (0)
Abstract 18482: Genetic and Pharmacologic Inhibition of Trem-1 Limits the Development of Experimental Atherosclerosis (2016) (0)
Apoptosis in Normal and Pathological Vessels (1999) (0)
Somatostatin receptor PET/MR imaging of large vessel inflammation in active compared with inactive vasculitis and atherosclerosis (2022) (0)
117 Longitudinal follow-up study of arterial structure in patients with severe psoriasis and treated with ustekinumab or with tumor necrosis factor alpha inhibitors (2022) (0)
P12 EFFECTS OF GADD34, GROWTH ARREST AND DNA DAMAGE-INDUCIBLE PROTEIN 34, ON ATHEROSCLEROSIS AND POST-ISCHEMIC CARDIAC INJURY (2018) (0)
Culture and Adenoviral Transduction of Bone Marrow – Derived Macrophages (2007) (0)
REVIEW ARTICLES Regulatory T-Cell Immunity in Atherosclerosis (2007) (0)
Total antibody deficiency in B cell sufficient mice enhances atherosclerosis (2015) (0)
GDF15 antagonism limits severe heart failure and prevents cardiac cachexia in mice (2022) (0)
Abstract 5314: A Critical Role for TGF-{beta} Activity in the Protection Against Aortic Aneurysm Formation and Complications in Adult Mice (2009) (0)
CTGF deficiency predisposes to aneurysm generation and rupture. Mineralocorticoid antagonist as potential therapeutic treatment. (2021) (0)
ATVB In Focus Apoptotic Cell Death and Efferocytosis in Atherosclerosis (2012) (0)
Low- dose i nterleukin 2 for the reduction of v ascular inflammati o n in acute corona ry syndromes (IVORY): protocol and study rationale for a randomised, double- blind, placebo- controlled, phase II clinical trial (2022) (0)
MFGE8-dependent phagocytosis of apoptotic cells protects against atherosclerosis development and prevents necrotic core formation (2006) (0)
Repetitive exposure to apoptotic cells induces an acceleration of atherosclerosis in apolipoprotein E knockout mice (2006) (0)
Abstract: 557 APOPTOTIC CELL CLEARANCE AND IMMUNE REGULATION IN ATHEROSCLEROSIS (2009) (0)
Peptide-Based Vaccination Strategies to Promote Treg-Mediated Atheroprotection (2012) (0)
Characterization of a putative human immunoregulatory protein : the role of Tj 6 an [ H + ] $ ATPase $ like protein in lymphocyte activation (2003) (0)
Imaging of post-infarct myocardial inflammation with 68Ga-DOTATATE PET/MRI (2022) (0)
Mechanisms of accelerated atherosclerosis associated with IMIDs (2010) (0)
Abstract 63: MerTK and Mfge8-Dependent Efferocytosis Orchestrates Postischemic Cardiac Healing Through VEGF-A and Il-10 Regulation (2014) (0)
BMP 9 / BMP 10 enhance monocyte recruitment 1 Bone morphogenetic protein ( BMP ) 9 and BMP 10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2 (2017) (0)
Microparticle Elevation Following Subarachnoid Hemorrhage (2009) (0)
Abstract 1513: Lactadherin-Dependent Phagocytosis of Apoptotic Cells is Required for a Protective Immune Response in Atherosclerosis (2006) (0)
PL.5.3Role of T cell subsets in atherosclerosis: From mouse to human (2012) (0)
The role of CLEC9a in atherosclerosis development (2017) (0)
TREKING: TaRgEting NK cells in post-Ischemic cardiac remodeliNG (2023) (0)
Abstract 3666: Major Role of Ly6chi/7/4hi/ccr2+ Monocytes in Post-ischemic Neovascularization (2008) (0)
NR4A1 in marginal zone B cells decreases atherosclerosis (2020) (0)
Abstract 756: Continuous Subcutaneous Delivery Of Apolipoprotein B-derived Peptides Induces T Cells Anergy And Reduces The Progression Of Established Atherosclerosis In Mice (2007) (0)
[Autophagy in dendritic cells promotes atheroprotective regulatory T cells]. (2021) (0)
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health (2018) (0)
MFG-E8 in the Vascular System (2014) (0)
Role of the semicarbazide-sensitive amine oxidase (SSAO) in cell differentiation: Consequences in atherosclerosis (2012) (0)
4.W20.4 Anti-inflammatory cytokines in the human atherosclerotic plaque (1997) (0)
Nationwide Study of Mortality After Abdominal Aortic Aneurysm Repair in France 2010- 2019 (2021) (0)
Global And Haematopoietic Cd22 Deficiency In Ldlr-/- Mice Reduce Plasma Triglyceride And Cholesterol Levels Without Affecting Lesion Formation (2019) (0)
Author Correction: JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm (2022) (0)
New emerging roles for B cells in atherosclerosis (2012) (0)
Secreted IgM deficiency leads to increased BCR signaling that results in abnormal splenic B cell development (2017) (0)
Use of inhibitors of IL-18 for the treatment and / or prevention of peripheral vascular diseases. (2003) (0)
P4.08: BIOMECHANICAL STUDY OF ANEURYSM RUPTURE (0)
D025 Phagocytosis is pivotal in the beneficial effect of bone marrow mononuclear cellsbased therapy for myocardial infarction (2009) (0)
Abstract 322: Exploring the Role of Triggering Receptor Expressed on Myeloid Cells-1 in Experimental Abdominal Aortic Aneurysm (2018) (0)
Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: a 21‐year cohort (2019) (0)
Abstract 19754: Specific Overexpression of Fc Gamma Receptor IIb on Macrophages Reduces Atherosclerosis in Ldlr Deficient Mice (2010) (0)
P156 PLA2G2A, PLA2G5 AND PLA2G10 VARIANTS, SPLA2 ACTIVITY AND MASS AND CHD RISK: RESULTS FROM GRACE AND EPIC-NORFOLK (2010) (0)
D022 Natural CD4/CD25/Foxp3 regulatory t cells modulate post-ischemic inflammatory response: role in neovascularization (2009) (0)
[Deleterious role of spleen marginal zone B lymphocytes in ventricular remodeling after myocardial infarction]. (2022) (0)
MHC Class II-Restricted Antigen Presentation by Plasmacytoid Dendritic Cells Drives Pro-Atherogenic T Cell Immunity Running title: Sage et al.; MHC II expression by pDC promotes atherosclerosis (2014) (0)
Abstract 81: B Lymphocytes Trigger MCP3-Dependent Mobilization of Monocytes and Promote Adverse Ventricular Remodeling After Myocardial Infarction (2012) (0)
1141. Phase 3 Trial (in progress) of the SYK Inhibitor Fostamatinib in Patients Hospitalized with COVID-19: Protocol and Study Implementation Updates (2022) (0)
Abstract 15: The Cardio-renal Effects Of Il-33 Treatment In Myocardial Infarction-induced Kidney Damage (2021) (0)
A032 Specific overexpression of FcgRIIb on macrophages reduces atherosclerosis in LDLr deficient mice (2009) (0)
BAFF (B Cell Activating Factor) Receptor Deficiency Reduces the Development of Atherosclerosis in Mice (2012) (0)
MicroRNA 21 and Hypoxia Inducible Factor 1 coordinate the impact of B lymphocytes on cardiac function after acute myocardial infarction (2017) (0)
FC gamma receptor IIb controls humoral responses to atherosclerosis (2018) (0)
Mallat Recent Highlights of ATVB : Macrophages (2017) (0)
Themed Section: Targeting Inflammation to Reduce Cardiovascular Disease Risk (2017) (0)
Vaccination contre l'athérosclérose: lymphocytes T régulateurs et induction de tolérance (2009) (0)
Abstract 135: Exploration and Modulation of TREM-1 in Experimental Atherosclerosis (2013) (0)
Adaptive T Cell Immunity (2012) (0)
129 The CHR9P21 risk locus affects IL-1/TLR signalling in VSMC (2018) (0)
Méthode et composition pharmaceutique destinée à être utilisée dans le traitement ou la prévention d'un anévrisme (2013) (0)
Use of inhibitors of IL-18 for the treatment and / or prevention of atherosclerosis. (2001) (0)
Méthodes et trousses permettant de prédire le risque de survenue d'un événement cardiovasculaire chez un sujet (2012) (0)
MISE AU PoINT (2011) (0)
L'apoptose en clinique cardiovasculaire (1997) (0)
Implication de l’immunité innée au-delà de la réponse à l’infection — L’athérosclérose: une maladie inflammatoire (2011) (0)
I012 Transforming growth factor-beta activity in macrophages protects from angiotensin ii-induced aortic aneurysm in mice (2009) (0)
Biomarqueurs circulants et tissulaires et risques cardiovasculaires (2007) (0)
Inflammation et athérosclérose (2004) (0)
Biologie des accidents ischémiques aigus : stabilité des plaques, inflammation, thrombose, et mort cellulaire par apoptose (2001) (0)
Les lymphocytes t régulateurs protègent contre le développement de l'athérosclérose (2007) (0)
La lactadhérine, acteur de l'angiogenèse (2005) (0)
« La lactadhérine, nouvel acteur de l'angiogenèse / Lactadherin promotes VEGF-dependent neovascularization » (2016) (0)
Utilisation de polypeptides il-17 pour une utilisation dans la prévention ou le traitement de l'athérosclérose (2010) (0)
L’endocardite à Bartonella quintana et à Bartonella henselae est associée à la présence de fort taux d’anticorps anti-protéinase 3 (2013) (0)
Rôle de l'inflammation et de l'apoptose dans la rupture de la plaque d'athérosclérose (2002) (0)
Athérosclérose : inflammation et « désinflam-mation » (2000) (0)
Utilisation d'inhibiteurs il-18 pour le traitement et/ou la prevention de l'atherosclerose (2001) (0)
Immunité de l’athérosclérose : rôle des lymphocytes T-régulateurs (2006) (0)
Fragilisation/stabilisation des plaques. Rôle de l’inflammation (2005) (0)
L’autophagie dans les cellules dendritiques promeut des lymphocytes CD4+ protecteurs contre l’athérosclérose (0)
Will gazing into the single-cell multiome illuminate cardiovascular drug development? (2023) (0)
Deficiency of secreted IgM antibodies causes increased plasma IgE levels that promote atherosclerosis (2016) (0)
Méthodes et compositions pharmaceutiques destinées au traitement de l'obésité (2017) (0)
P6598MicroRNA 21 and Hypoxia Inducible Factor 1 synchronize the impact of B lymphocytes on cardiac function after acute myocardial infarction (2019) (0)
174 Total antibody deficiency in B cell sufficient mice enhances atherosclerosis (2015) (0)
MiR-21 Deficiency Alters the Survival of Ly-6Clo Monocytes in ApoE -/- Mice and Reduces Early-Stage Atherosclerosis. (2019) (0)
Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells (2017) (0)
Recent Highlights of ATVB (2014) (0)
Rôle de l’inflammation dans le développement et l’instabilité de la plaque d’athérosclérose : perspectives thérapeutiques (2003) (0)
Dissection of the role of natural killer cells in atherosclerosis using selective genetic approaches. (2017) (0)
MHC class II-restricted antigen presentation by plasmacytoid dendritic cells drive pro-atherogenic immunity (2014) (0)
P4.10: THE SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO): A NEW ACTOR IN ATHEROSCLEROSIS IN THE APOE MOUSE MODEL? A ACTOR IN ATHEROSCLEROSIS IN THE (0)
Abstract 93: Natural CD4+CD25+ Regulatory T Cells Control the Development and Complications of Abdominal Aortic Aneurysm in Mice (2012) (0)
Coronary Heart Disease Phospholipase A2 Enzymes, High-Dose Atorvastatin, and Prediction of Ischemic Events After Acute Coronary Syndromes (2012) (0)
Abstract: S2-26 ROLE OF CYTOKINES IN ATHEROPROTECTION (2009) (0)
Abstract 5448: Regulatory T Cells Control Post-Ischemic Neovascularization (2008) (0)
Combination of sPLA2 activity and cardiovascular risk factors OxPL / apoB for diagnosis / prognosis of a disease / cardiovascular event (2009) (0)
Procédés de production d'un modèle animal non humain pour un anévrysme de l'aorte (2008) (0)
We-W41:2 Pathogenic and regulatory immune pathways in atherosclerosis. Implications for risk determination (2006) (0)
Oc026—Impact Of Circulating Levels Of Interleukin-17 And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction (2013) (0)
TGFB β protects from aortic rupture in a murine model of aneurysm induced by elastase (2017) (0)
Chromosome 9P21 association with cardiovascular diseases; altered inflammatory signalling in VSMCS? (2015) (0)
Indoleamine 2,3-dioxygenase aggravates cardiac function and left ventricular remodeling after acute myocardial infarction (2018) (0)
Abstract 1739: Fractalkine/CX3CR1 and MCP-1/CCR2 Act in a Complementary Way to Promote the Development of Atherosclerosis (2006) (0)
Pro-atherogenic high fat diet accelerates tumor growth in mice through activation of innate immunity (2018) (0)
"Plaque erosion" or the danger of eerily quiet appearance. (2021) (0)
Detective leptin signaling improves regulatory T cell immune response and protects mice from atherosclerosis (2007) (0)
MR imaging of an arachidonic acid-induced mouse model of thrombosis using an activated platelets-targeted paramagnetic contrast agent (2008) (0)
Beating (T Lymphocyte-driven) Atherosclerosis with BTLA. (2019) (0)
Transplantation of Bone Marrow–Derived Mononuclear Cells in Ischemic Apolipoprotein E–Knockout Mice Accelerates Atherosclerosis Without Altering Plaque Composition Brief Rapid Communication (2003) (0)
P5 VASCULAR SMOOTH MUSCLE CELL PLASTICITY IN DISSECTING AORTIC ANEURYSMS (2018) (0)
Fishing CHIPs to Predict Postoperative Atrial Fibrillation. (2023) (0)
Abstract 19913: In vivo Characterization of a New Abdominal Aortic Aneurysm (AAA) Mouse Model with Conventional and Molecular MRI (2010) (0)
Abstract 14757: Role Of Stat3 Signalling In Aneurysm Development (2011) (0)
Stem Cell Biology (2005) (0)
Rôle délétère des lymphocytes B de la zone marginale de la rate dans le remodelage ventriculaire après un infarctus du myocarde (2022) (0)
The effects of dyslipidaemia and cholesterol modulation on erythrocyte susceptibility to malaria parasite infection (2019) (0)
Abstract 14742: A Concomitant Switch Towards Th17 And Treg Responses Mediates Atheroprotection In T-bet-deficient Mice (2011) (0)
In vivo electrotransfer of interleukin-10-encoding plasmid prevents diet-induced endothelial activation (2000) (0)
Neuroimmune cardiovascular interfaces control atherosclerosis (2022) (0)
NEUTROPHIL-DERIVED MICROPARTICLES ARE RELEASED INTO THE CORONARY CIRCULATION FOLLOWING CORONARY INTERVENTION IN ACUTE CORONARY SYNDROME PATIENTS (2016) (0)
Abstract 377: Angiotensin II Drives Murine Ly-6chi Monocyte Trafficking from the Spleen to the Aneuvrismal Aorta Through B Cells (2014) (0)
Pro- and anti-inflammatory balance and atherosclerosis (2000) (0)
Abstract 226: C-type Lectin Receptor Clec9a on Cd8a+ Dendritic Cells Promotes the Development of Atherosclerosis in Mice (2017) (0)
Atherosclerosis as inflammation – a controversial concept becomes accepted (2008) (0)
[Lactadherin promotes VEGF-dependent neovascularization]. (2005) (0)
TOWARDS NOVEL CIRCULATING MARKERS FOR ABDOMINAL AORTIC ANEURYSM PROGNOSIS (2021) (0)
Clec4e signaling promotes pro-atherogenic macrophage responses. (2017) (0)
Selective EGF-Receptor deletion in myeloid cells limits atherosclerosis (2017) (0)
Abstract 490: Distribution of Oxidized Phospholipids and Lipoprotein-Associated Phospholipase A2 in Plasma, Density Gradient Fractions and Individual Lipoproteins in Patients with Familial Hypercholesterolemia: Effect of LDL Apheresis (2012) (0)
Systemic Delivery of Murine IL-10 by Intramuscular Injection of Expression Plasmid (1999) (0)
Ccn2 deletion predisposes to aortic aneurysm formation and death in mice which is partially reduced by mineralocorticoid receptor antagonist treatment (2021) (0)
[Inflammation and atheroma --recent developments]. (2006) (0)
Limits of Mendelian Randomization Analyses in Selection of Secretory Phospholipase A(2)-IIA as a Valid Therapeutic Target for Prevention of Cardiovascular Disease Reply (2014) (0)
259 Carotid intima media thickness is related to HIV duration and decreased anti inflammatory status but not to antiretroviral treatment exposure. The CHIC (Collaboration on HIV, inflammation and Cardiova) (2012) (0)
P3.15: LARGE EDDY SIMULATION OF AORTIC COARCTATION BEFORE AND AFTER SURGERY (0)
Abstract 585: Card9 Deficiency Accelerates Experimental Atherosclerosis (2018) (0)
Cellular origin and thrombogenic activity of microparticles isolated from human atherosclerotic plaques (2006) (0)
Blockade of Transforming Growth Factor Beta Activity in Elastase-Induced Aortic Injury in Mice Induces a Human-Like Abdominal Aneurysm (2017) (0)
Abstract 18929: The Role of Clec9a in Atherosclerosis Development (2016) (0)
Abstract 15489: Circulating Levels of Interleukin-17 and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction (2012) (0)
Lactadherin‐Dependent Phagocytosis and Clearance of Oxidized Erythrocytes Following Intra‐Plaque Hemorrhage (2007) (0)
Autoévaluations de l'article : Physiopathologie de l'athérosclérose (2013) (0)
Role of indoleamine 2,3 dioxygenase in abdominal aortic aneurysm development. (2017) (0)
Keeping our hearts "NEAT"? (2019) (0)
Adapting treatments for adaptive immunity in ischaemic heart disease. (2022) (0)
Abstract 1736: Deficiency in Mer Receptor Tyrosine Kinase Induces Accumulation of Apoptotic Debris and Acceleration of Atherosclerosis in Mice (2006) (0)
W7 DEFICIENT CD40-TRAF6 SIGNALING IN LEUKOCYTES PREVENTS ATHEROSCLEROSIS BY SKEWING THE IMMUNE RESPONSE TOWARDS AN ANTI-INFLAMMATORY PROFILE (2010) (0)
Deletion of chromosome 9P21 noncoding cardiovascular risk interval in mice induces a prothrombotic phenotype (2016) (0)
Abstract 47: Role of Indoleamine 2,3-dioxygenase in Atherosclerosis Development (2013) (0)
The role of the inflammasome in cardiovascular diseases (2014) (0)
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells (2023) (0)
[Inflammation and atherosclerosis]. (2003) (0)
Marginal Zone B cells control follicular helper T cell response to high cholesterol diet. (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ziad Mallat?

Ziad Mallat is affiliated with the following schools:

Ziad Mallat's Academic­Influence.com Rankings

Ziad Mallat's Degrees

Similar Degrees You Can Earn

Why Is Ziad Mallat Influential?

Ziad Mallat's Published Works

Published Works

What Schools Are Affiliated With Ziad Mallat?

Ziad Mallat's AcademicInfluence.com Rankings